Navigation Links
ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
Date:9/27/2007

HALIFAX, Sept. 27 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT) finalizes an important step in its progress with the last appointment to its scientific advisory board (SAB), international oncology expert, Dr. Neil Berinstein.

Dr. Berinstein is the Global Head of the Cancer Vaccine Program at sanofi pasteur, and a professor at the University of Toronto's Department of Medicine. He has a long track record in fundamental research and has a significant publication record in the area of normal and malignant B cell biology, including articles, abstracts and book chapters on immunotherapeutic approaches for cancer including cancer vaccines. He was recently appointed vice-president of the Sabin Institute Cancer vaccine consortium. Dr. Berinstein received an MD from the University of Manitoba, and completed training programs at the University of Toronto in Internal Medicine and Medical Oncology. Following this, he spent four years as a post-doctoral fellow in Dr. Ron Levy's Lab at Stanford University working in the area of immunotherapy for cancer.

"IVT has very promising science," remarked Dr. Berinstein. "Their work is particularly interesting to me, and my commitment to new immunotherapeutic approaches for patients with cancer. "

ImmunoVaccine Technologies Inc. has been actively recruiting members to its SAB in preparation for its Phase I clinical trials, and sees this final appointment as a major stepping stone to that goal.

"This final appointment is one of the last steps before our Phase I clinical trials," said Dr. Martin Kast, chair of the scientific advisory board. "Dr. Berinstein's experience and insight are reflective of the quality of professionals that our exciting projects have attracted," continued Kast.

"Dr. Berinstein is a valuable addition to the team, and represents a pivotal point in our ongoing plan to introduce our patented vaccine platform," commented Dr. Randal Chase, president and CEO of IVT.

ImmunoVa
'/>"/>

SOURCE ImmunoVaccine Technologies Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 02, 2015 Research and Markets ... of the "2015 Strategies in the ... to their offering. This new ... immunoprotein diagnostic market, including emerging tests, technologies, ... profiles of leading suppliers. During ...
(Date:6/3/2015)... Minn. , June 3, 2015 ... that supports the entire spectrum of clinical research, is ... iMedNet eClinical technology platform will ... by the end of this month.  iMedNet ... – built from the ground up by MedNet Solutions, ...
(Date:6/3/2015)... 2015 Typical racks for laboratory freezers ... and depths often taking up unnecessary room in already ... Low 5 Box Freezer Racks offer a customizable ... freezer storage boxes and freezers. , “These racks ... experiments or multiple people because users can configure freezer ...
(Date:6/3/2015)... 2015 Green Earth Energy has restructured ... support the RCBC Waste to Energy system. Paul ... the family business, http://www.greenearthwaste.com which has been ... added recycling to their waste collection services in 2012 ... the Fortune 500 companies with manufacturing plants in West ...
Breaking Biology Technology:United States Strategies in the Immunoprotein Diagnostic Testing Market Report 2015 2MedNet Announces "2015 Feature 1" Release Of iMedNet eClinical 2Freezer Space Can Now Be Configured Your Way with New Modular Freezer Racks 2
... BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), ... that at ATS Labs, using a Quantitative Disk ... (C.diff) spores, BioNeutral,s Ygiene(TM) Hospital Grade antimicrobial delivered ... Clostridium Difficile, an extremely dangerous and difficult to ...
... Novavax, Inc. (Nasdaq: NVAX ) ... their joint venture in India under the agreement signed ... joint venture, called CPL Biologicals Pvt. Ltd., will develop ... using technology contributed from Novavax and Cadila Pharmaceuticals. ...
... safety of their drinking water for granted, that ordinary tap ... of Tel Aviv University,s School of Physics and Astronomy. ... natural disaster or sabotage, the physicist has developed a new ... water supply in real time. Modifying special fibers ...
Cached Biology Technology:BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase 2BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase 3Cadila Pharmaceuticals Launches Joint Venture With Novavax in India 2Cadila Pharmaceuticals Launches Joint Venture With Novavax in India 3Cadila Pharmaceuticals Launches Joint Venture With Novavax in India 4Monitoring water through a snake's eyes 2Monitoring water through a snake's eyes 3
(Date:5/29/2015)... May 28, 2015 Research and Markets ... the "Facial Recognition Market by Solution, by ... Forecast to 2020" report to their offering. ... facial recognition technology become more efficient and cost ... traction and investment from the commercial sector. The ...
(Date:5/27/2015)... , May 27, 2015   ... medication safety systems and image documentation solutions ... of comprehensive, technologically-advanced automation solutions, is pleased ... integration. The Codonics® Safe Label System® (SLS), ... in conjunction with the Omnicell Anesthesia Workstation, ...
(Date:5/25/2015)... -- Australia,s market for wearable technologies is considered to be ... of several trials and prototypes. The release of the ... ignite interest in wearables as well as accelerate sales ... This in turn will spur greater innovation from other ... vendors and distributors. Photo - ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4
... reserves such as gold, diamond and natural gas isn,t ... look. Now researchers at Tel Aviv University have modernized the ... signs of lucrative resources that could lurk beneath our feet. ... first time, Prof. Lev Eppelbaum of TAU,s Department of ...
... Bethesda, MDA new research report published in The ... and scientists better understand a rare genetic disease that ... decreased vision called Enhanced S-Cone Syndrome or Goldman-Favre Syndrome. ... genes responsible for the healthy renewal of rods and ...
... had officials along the East Coast preparing for mass ... the University of Delaware were grabbing their best data ... It was a rare opportunity for the scientists ... as Irene threatened to be the biggest hurricane to ...
Cached Biology News:The geophysicist's guide to striking it rich 2Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained 2Hurricane Irene: Scientists collect water quality and climate change data from huge storm 2
... include: ,ICC and IHC Protocol Development ... ,Antibody Screenings in Animal or Human ... of Cells and Tissues ,Peroxidase, Alkaline ... Fluorescent, or Electron Microscopy ,Protein Localization ...
... the optimization of immunostaining. ... the primary antibody, selection and ... Alk. Phos., HRP, fluorescence, or ... evaluation by light or fluorescence ...
Request Info...
Request Info...
Biology Products: